Teclistamab (Tecvayli) has been recommended for use by the NHS in England and Wales as a fourth-line option for treating relapsed and refractory multiple myeloma in adults. In final draft guidance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback